Investor Alert

press release

May 10, 2022, 6:00 a.m. EDT

Haemonetics 4th Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website

May 10, 2022 (PRNewswire via COMTEX) -- PR Newswire

BOSTON, May 10, 2022

Financial release accessible online

BOSTON, May 10, 2022 /PRNewswire/ -- Haemonetics Corporation /zigman2/quotes/205816408/composite HAE -1.20% announced that financial results for its fourth quarter fiscal 2022, which ended April 2, 2022, are available on its Investor Relations website.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. EDT on May 10, 2022. The conference call and webcast can be accessed with the following information:

  • U.S. / Canada toll free (877) 848-8880; International (716) 335-9512

  • Conference ID required for access: 5347317

  • A live webcast of the call can be accessed on Haemonetics' Investor Relations website or via the following link: https://edge.media-server.com/mmc/p/gooqch6s

In addition, the Company has posted to its Investor Relations website the earnings release and analytical tables and supplemental information that will be referenced on its conference call and webcast, direct links to which are available below.

Direct link to 4 Q FY22 Earnings Release :

Direct link to 4 Q FY22 Analytical Tables and Supplemental Information: https://haemonetics.gcs-web.com/static-files/52e9f8bf-c0fc-490a-af79-5fe4fef86e06

A replay of the conference call and webcast will be available for one year beginning on May 10, 2022, at 11:00 a.m. EDT using the conference call webcast link provided in this press release.

About Haemonetics Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com .

Investor Contacts:
Olga Guyette, Sr. Director-Investor Relations & Treasury David Trenk, Manager-Investor Relations
(781) 356-9763 (203) 733-4987
olgaguyette@haemoneticscom davidtrenk@haemoneticscom

Media Contact:
Josh Gitelson, Director-Global Communications
(781) 356-9776

View original content to download multimedia: https://www.prnewswire.com/news-releases/haemonetics-4th-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website-301543450.html

SOURCE Haemonetics Corporation


Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright (C) 2022 PR Newswire. All rights reserved

$ 65.18
-0.79 -1.20%
Volume: 849,277
June 30, 2022 4:00p
P/E Ratio
Dividend Yield
Market Cap
$3.38 billion
Rev. per Employee


Partner Center

Link to MarketWatch's Slice.